Our study elucidated the precise molecular mechanism of how ERS‐CAF contributed to chordoma progression, which may offer an insight into the development of novel therapeutic strategies possibly by targeting the IER2/GMFG/ITGB1 signaling axis to break the communication between ERS‐CAF and tumor cells. This evidence concerns the gene IER2 and neoplasm.